-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Immune Microenvironment and GVL Effects

Program: Scientific Program
Session: Host Factors Driving Anti-Leukemia Immunotherapy Outcomes
Hematology Disease Topics & Pathways:
Clinical trials, Research, Genomics, Bioinformatics, Clinical Research, Immunology, Biological Processes, Molecular biology, Technology and Procedures
Saturday, December 7, 2024, 2:00 PM-3:15 PM

Catherine J. Wu, MD

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Disclosures: Wu: Repertoire: Membership on an entity's Board of Directors or advisory committees; Adventris: Membership on an entity's Board of Directors or advisory committees; Pharmacyclics: Research Funding; BioNtech, Inc: Current equity holder in publicly-traded company; Aethon Therapeutics: Membership on an entity's Board of Directors or advisory committees.

See more of: Host Factors Driving Anti-Leukemia Immunotherapy Outcomes
See more of: Scientific Program
Previous Presentation | Next Presentation >>